AdvisorNet Financial Inc grew its stake in Healthpeak Properties (NASDAQ:PEAK) by 297.0% during the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 6,043 shares of the company’s stock after acquiring an additional 4,521 shares during the period. AdvisorNet Financial Inc’s holdings in Healthpeak Properties were worth $167,000 at the end of the most recent reporting period.
Other hedge funds also recently modified their holdings of the company. Tower Research Capital LLC TRC grew its stake in Healthpeak Properties by 1,866.7% in the 1st quarter. Tower Research Capital LLC TRC now owns 1,180 shares of the company’s stock worth $28,000 after acquiring an additional 1,120 shares in the last quarter. CVA Family Office LLC bought a new position in Healthpeak Properties in the 1st quarter worth about $41,000. Costello Asset Management INC bought a new position in Healthpeak Properties in the 2nd quarter worth about $54,000. NuWave Investment Management LLC bought a new position in Healthpeak Properties in the 2nd quarter worth about $53,000. Finally, First Horizon Advisors Inc. grew its stake in Healthpeak Properties by 59.5% in the 2nd quarter. First Horizon Advisors Inc. now owns 2,022 shares of the company’s stock worth $56,000 after acquiring an additional 754 shares in the last quarter.
A number of equities analysts have commented on PEAK shares. Morgan Stanley upped their target price on shares of Healthpeak Properties from $28.00 to $29.00 and gave the stock an “equal weight” rating in a research note on Friday, August 21st. Barclays increased their price objective on shares of Healthpeak Properties from $28.00 to $30.00 and gave the company an “overweight” rating in a research note on Friday, September 4th. Berenberg Bank initiated coverage on shares of Healthpeak Properties in a research note on Thursday, July 2nd. They set a “hold” rating on the stock. Stifel Nicolaus initiated coverage on shares of Healthpeak Properties in a research note on Tuesday, September 1st. They set a “buy” rating and a $31.00 price objective on the stock. Finally, Citigroup increased their price objective on shares of Healthpeak Properties from $24.00 to $28.00 and gave the company a “neutral” rating in a research note on Thursday, July 2nd. Six analysts have rated the stock with a hold rating and seven have given a buy rating to the company. The company currently has an average rating of “Buy” and an average price target of $28.91.
Healthpeak Properties (NASDAQ:PEAK) last posted its earnings results on Tuesday, August 4th. The company reported $0.09 EPS for the quarter, missing the Zacks’ consensus estimate of $0.40 by ($0.31). The company had revenue of $588.40 million for the quarter, compared to the consensus estimate of $619.25 million. Healthpeak Properties’s revenue was up 20.3% on a year-over-year basis.
The business also recently declared a quarterly dividend, which was paid on Tuesday, August 25th. Shareholders of record on Friday, August 14th were issued a $0.37 dividend. The ex-dividend date of this dividend was Thursday, August 13th. This represents a $1.48 dividend on an annualized basis and a dividend yield of 5.56%.
Healthpeak Properties Profile
Healthpeak Properties, Inc is a fully integrated real estate investment trust (REIT) and S&P 500 company. Healthpeak owns and develops high-quality real estate in the three private-pay healthcare asset classes of Life Science, Senior Housing and Medical Office, designed to provide stability through the inevitable industry cycles.
Further Reading: Are sell-side analysts objective?
Receive News & Ratings for Healthpeak Properties Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Healthpeak Properties and related companies with MarketBeat.com's FREE daily email newsletter.